Expression Vector Construction and HEK-293 Cell Transfection

PS Peter R. Strege
AM Amelia Mazzone
CB Cheryl E. Bernard
LN Leila Neshatian
SG Simon J. Gibbons
YS Yuri A. Saito
DT David J. Tester
MC Melissa L. Calvert
EM Emeran A. Mayer
LC Lin Chang
MA Michael J. Ackerman
AB Arthur Beyder
GF Gianrico Farrugia
request Request a Protocol
ask Ask a question
Favorite

For each mutation, the appropriate nucleotide changes were engineered by site-directed mutagenesis into a construct containing the most common splice variant of SCN5A (hH1c1, GenBank AC137587) (27) to encode an altered Na+ channel α-subunit, NaV1.5, using the QuikChange II XL site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA) according to the manufacturer’s instructions. The integrity of the constructs and the presence of the desired mutation were verified by DNA sequencing. The primers used for mutagenesis are listed in Table 1. Wild-type (WT) (27) or mutant constructs were cotransfected with pEGFP-C1 (Clontech, Palo Alto, CA) into HEK-293 cells (American Type Culture Collection, Manassas, VA) using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA), as described previously (8, 37). After overnight culture, transfected cells positive for green fluorescent protein (GFP) were selected for whole cell voltage clamp.

Primers used for mutagenesis

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A